Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2025

May 15, 2025

30150_dirs_2025-05-15_ff401b22-8769-4ac0-895a-d848620a9a34.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-05-13

Reporting Person: Smith Michael Alexander (Chief Legal Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-13 Common Stock S 4407 $67.81 Disposed 92203 Direct
2025-05-14 Common Stock S 409 $65.61 Disposed 91794 Direct

Footnotes

F1: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.